The Prognostic Role of Genes with Skewed Expression Distribution in Lung Adenocarcinoma
Many studies assumed gene expression to be normally distributed. However, some were found to have left-skewed distribution, while others have right-skewed distribution. Here, we investigated the gene expression distribution of five lung adenocarcinoma data sets. We assumed that samples in the tail and non-tail of a skewed distribution were drawn from different populations with different survival outcomes. To investigate this hypothesis, skewed genes were detected to build a tail indicator matrix comprising of binary values. Survival analysis revealed that patients with more skewed genes in their tails had worse survival. Hierarchical clustering of the tail indicator matrices discovered a gene set with similar tail configurations for either left or right skewed genes. The two gene sets divided patients into three groups with different survivals. In conclusion, there is a direct association between genes with skewed distribution and the prognosis of lung adenocarcinoma patients.
KeywordsSkewed distribution Gene expression RNA-sequencing Microarray Survival Lung adenocarcinoma
This work was supported by the Zhi-Yuan chair professorship start-up grant (WF220103010) from Shanghai Jiao Tong University.
- 1.Der, S.D., Sykes, J., Pintilie, M., Zhu, C.Q., Strumpf, D., Liu, N., Jurisica, I., Shepherd, F.A., Tsao, M.S.: Validation of a histology-independent prognostic gene signature for early-stage, non-small-cell lung cancer including stage IA patients. J. Thorac. Oncol. 9(1), 59–64 (2014)CrossRefGoogle Scholar
- 7.Meyer, D., Dimitriadou, E., Hornik, K., Weingessel, A., Leisch, F., Chang, C.C., Lin, C.C., Meyer, M.D.: Package e1071 (2017)Google Scholar
- 11.Schabath, M.B., Welsh, E.A., Fulp, W.J., Chen, L., Teer, J.K., Thompson, Z.J., Engel, B.E., Xie, M., Berglund, A.E., Creelan, B.C., et al.: Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinoma. Oncogene 35, 3209 (2015)CrossRefGoogle Scholar
- 12.Shedden, K., Taylor, J.M., Enkemann, S.A., Tsao, M.S., Yeatman, T.J., Gerald, W.L., Eschrich, S., Jurisica, I., Giordano, T.J., Misek, D.E., et al.: Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat. Med. 14(8), 822–827 (2008)CrossRefGoogle Scholar
- 13.Stewart, B., Wild, C.P., et al.: World cancer report 2014 (2014)Google Scholar
- 18.Watanabe, H., Francis, J.M., Woo, M.S., Etemad, B., Lin, W., Fries, D.F., Peng, S., Snyder, E.L., Tata, P.R., Izzo, F., et al.: Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target. Genes Dev. 27(2), 197–210 (2013)CrossRefGoogle Scholar